A New Way to Assess the Trajectory of Remission in Crohn Disease: Correlating Drug Levels With a Noninvasive Blood Biomarker of Mucosal Remission

Detalles Bibliográficos
Autores principales: Gremida, Anas, Deepak, Parakkal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Editorials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802407/
https://www.ncbi.nlm.nih.gov/pubmed/36776653
http://dx.doi.org/10.1093/crocol/otab036
_version_ 1784861675271225344
author Gremida, Anas
Deepak, Parakkal
author_facet Gremida, Anas
Deepak, Parakkal
author_sort Gremida, Anas
collection PubMed
description
format Online
Article
Text
id pubmed-9802407
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-98024072023-02-10 A New Way to Assess the Trajectory of Remission in Crohn Disease: Correlating Drug Levels With a Noninvasive Blood Biomarker of Mucosal Remission Gremida, Anas Deepak, Parakkal Crohns Colitis 360 Editorials Oxford University Press 2021-06-12 /pmc/articles/PMC9802407/ /pubmed/36776653 http://dx.doi.org/10.1093/crocol/otab036 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Crohn's & Colitis Foundation. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorials
Gremida, Anas
Deepak, Parakkal
A New Way to Assess the Trajectory of Remission in Crohn Disease: Correlating Drug Levels With a Noninvasive Blood Biomarker of Mucosal Remission
title A New Way to Assess the Trajectory of Remission in Crohn Disease: Correlating Drug Levels With a Noninvasive Blood Biomarker of Mucosal Remission
title_full A New Way to Assess the Trajectory of Remission in Crohn Disease: Correlating Drug Levels With a Noninvasive Blood Biomarker of Mucosal Remission
title_fullStr A New Way to Assess the Trajectory of Remission in Crohn Disease: Correlating Drug Levels With a Noninvasive Blood Biomarker of Mucosal Remission
title_full_unstemmed A New Way to Assess the Trajectory of Remission in Crohn Disease: Correlating Drug Levels With a Noninvasive Blood Biomarker of Mucosal Remission
title_short A New Way to Assess the Trajectory of Remission in Crohn Disease: Correlating Drug Levels With a Noninvasive Blood Biomarker of Mucosal Remission
title_sort new way to assess the trajectory of remission in crohn disease: correlating drug levels with a noninvasive blood biomarker of mucosal remission
topic Editorials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802407/
https://www.ncbi.nlm.nih.gov/pubmed/36776653
http://dx.doi.org/10.1093/crocol/otab036
work_keys_str_mv AT gremidaanas anewwaytoassessthetrajectoryofremissionincrohndiseasecorrelatingdruglevelswithanoninvasivebloodbiomarkerofmucosalremission
AT deepakparakkal anewwaytoassessthetrajectoryofremissionincrohndiseasecorrelatingdruglevelswithanoninvasivebloodbiomarkerofmucosalremission
AT gremidaanas newwaytoassessthetrajectoryofremissionincrohndiseasecorrelatingdruglevelswithanoninvasivebloodbiomarkerofmucosalremission
AT deepakparakkal newwaytoassessthetrajectoryofremissionincrohndiseasecorrelatingdruglevelswithanoninvasivebloodbiomarkerofmucosalremission

Ejemplares similares